Clinical Trial Update: Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated intravenous aflibercept in combination with FOLFIRI in Japanese patients with metastatic colorectal cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Neoplasms, Neoplasm Metastasis | Phase 1 | Status: COMPLETED